Srinagar, Aug. 18 -- By Dr. Fiaz Maqbool Fazili

A young woman walked into a clinic this year asking for tirzepatide, the injectable drug that has turned weight loss into a global obsession.

She was overweight and anxious and was already being monitored for a thyroid condition. After watching her sister struggle with diabetes, she hoped the injection would help her avoid the same fate.

The physician assessed her blood sugar, medical history and risk factors, then told her no, those reasons alone did not justify the drug. She left disappointed.

Days later, she sent a message that captured a frustration many doctors now encounter: she felt the physician had failed to satisfy her.

That single sentence explains why tirzepatide and its cou...